Last updated: 2026-09-23 06:44:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Bristol-Myers Squibb Co. (BMY) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $62.24, with a market capitalization of $127.91B and a P/E ratio of 13.70. Over the past 52 weeks, its price has ranged from $42.52 to $68.64. This page covers its latest market performance, valuation, price trends and company information.
$127.91B | |
$62.73 | |
$81.44 | |
$16.00 | |
$62.62 | |
6.12M | |
11.12M | |
13.70 | |
$68.64 | |
$42.52 | |
4.01% | |
-- |
Bristol-Myers Squibb Co. (BMY) last closed at $62.62 as of 2026-09-22 23:54:56, unchanged from the previous close of $62.62.
During the latest regular trading session, BMY traded between $16.00 and $81.44, with a volume of 6.12M shares. The closing price was near the upper end and near the upper end of its 52-week range.
Over the past seven days, Bristol-Myers Squibb Co. (BMY) moved from $64.10 to $62.24, representing a decline of 2.91% ($1.86).
The stock traded between $61.75 and $65.29 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.
The average daily volume was 13.93 million shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 75.5%
BMY is currently trading at $62.24, placing it 75.5% of the way from its 52-week low of $42.52 to its 52-week high of $68.64. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 32500 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of Bristol-Myers Squibb Co. (BMY) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.